Yersinia pestis is a tier 1 agent due to its contagious pneumopathogenicity, extremely rapid progression, and high mortality rate. As the disease is usually fatal without appropriate therapy, rapid detection from clinical matrices is critical to patient outcomes. We previously engineered the diagnostic phage ⌽A1122 with luxAB to create a "light-tagged" reporter phage. ⌽A1122::luxAB rapidly detects Y. pestis in pure culture and human serum by transducing a bioluminescent signal response. In this report, we assessed the analytical specificity of the reporter phage and investigated diagnostic utility (detection and antibiotic susceptibility analysis) directly from spiked whole blood. The bioreporter displayed 100% (n ‫؍‬ 59) inclusivity for Y. pestis and consistent intraspecific signal transduction levels. False positives were not obtained from species typically associated with bacteremia or those relevant to plague diagnosis. However, some non-pestis Yersinia strains and Enterobacteriaceae did elicit signals, albeit at highly attenuated transduction levels. Diagnostic performance was assayed in simple broth-enriched blood samples and standard aerobic culture bottles. In blood, <10 2 CFU/ml was detected within 5 h. In addition, Y. pestis was identified directly from positive blood cultures within 20 to 45 min without further processing. Importantly, coincubation of blood samples with antibiotics facilitated simultaneous antimicrobial susceptibility profiling. Consequently, the reporter phage demonstrated rapid detection and antibiotic susceptibility profiling directly from clinical samples, features that may improve patient prognosis during plague outbreaks.
Y
ersinia pestis, the causative agent of the plague, is a tier 1 agent carrying great risk for deliberate misuse and a significant socioeconomic, public health threat. Plague has the ability to spread person to person and is typically fatal in the absence of expedient antibiotic therapy. Over the last 20 years, there has been a global rise in plague incidence and strains have been isolated from patients with bubonic plague that are streptomycin and multidrug resistant (MDR) (1) (2) (3) . However, Y. pestis is typically not drug resistant, and recent data indicate that pneumonic plague may not be as transmissible as previously believed (4) . A zoonotic pathogen, Y. pestis circulates among rodents and lagomorph populations, with endemic foci found in Asia, Africa, the Americas, and the former Soviet Union. Most commonly spread to humans by fleas, plague typically begins by bacterial multiplication at the site of dermal inoculation, followed by spread to the draining lymph node via lymphatic vessels and the formation of characteristic buboes. Bubonic plague can rapidly progress to secondary septicemia, and in some cases, the bacteria can spread systemically and infiltrate alveoli, resulting in the highly lethal pneumonic form. Because of the potential for pneumonia ensuing from bubonic or septicemic plague, the CDC recommends quarantine of all plague patients (5) . Of greatest concern in bioterrorism is primary pneumonic plague contracted via inhalation of aerosolized bacilli, which frequently leads to septicemia. Pneumonic plague can be spread person to person and, like septicemic plague, is nearly always fatal without appropriate antibiotic therapy and aggressive supportive care within 18 to 24 h of symptom onset (6) .
Plague is definitively diagnosed by the isolation and identification of the organism from clinical specimens or by demonstrating a 4-fold or greater change in antibody titer against the F1 antigen in paired serum specimens. Because Y. pestis grows slowly (doubling time of 1.25 h at 28°C), culturing from clinical specimens can involve incubation for 24 to 72 h. Antibiotic susceptibility analysis from colony isolates requires an additional 24 to 48 h (7, 8) and thus can extend the total diagnostic timeline to between 2 and 5 days. However, because of the fulminant nature of plague infection, rapid appropriate antibiotic therapy is paramount to patient prognosis. Therefore, faster methods of detection and antimicrobial susceptibility profiling of Y. pestis directly from clinical matrices may be valuable.
Classical phage lysis assays using the plague diagnostic phage ⌽A1122 are utilized by the WHO, CDC, and public health laboratories for Y. pestis identification. Thought to target receptors likely essential for growth and virulence (9-11), ⌽A1122 infects and lyses all but two out of thousands of Y. pestis strains (12) . In order to increase the time to detection and bypass the necessity for pure cultures, ⌽A1122 was previously genetically engineered with the genes encoding bacterial luciferase (luxA and luxB) to create a reporter phage capable of transducing bioluminescence to infected cells (13) . The reporter phage ⌽A1122::luxAB was able to rapidly transduce a bioluminescent phenotype (Յ20 min) and sensitively detect Y. pestis in pure culture and in spiked human serum, thereby displaying promise as a diagnostic tool. In addition, as phage infection and gene expression are proportional to cell fitness, the reporter phage can rapidly generate antimicrobial susceptibility data from pure cultures, which correlate closely to results obtained using standard methods (14) . In this report, we examine the diagnostic performance of the Y. pestis reporter phage directly from blood and from commercial blood culture bottles and evaluate critical diagnostic parameters. Phage. The Y. pestis diagnostic phage ⌽A1122::luxAB was described previously (14) . Reporter phage stocks were prepared from Y. pestis A1122 using agar overlays. Phage were eluted from the top agar in SM buffer, clarified by centrifugation (4,000 ϫ g for 10 min), and vacuum-filter sterilized (0.22 M) twice before treatment with 1 M NaCl and precipitation with 8% polyethylene glycol (BioUltra 8000; Sigma-Aldrich, St. Louis, MO). The phage precipitate was resuspended in ϳ1/10 original volume of SM buffer and adjusted to a concentration of 1 ϫ 10 10 to 1 ϫ 10 11 PFU/ml. Filter sterilization was repeated for concentrated preparations and confirmed by negative culture on Luria-Bertani (LB) agar. Preparations were stored at 4°C.
MATERIALS AND METHODS

Bacterial
Bacterial growth and manipulation. Frozen stocks (in 25% glycerol at Ϫ70°C) of Y. pestis A1122 and the 58 virulent strains were individually streaked onto brain heart infusion (BHI) agar with 6% sheep blood agar (SBA) and LB agar, respectively, and incubated for 48 h at 28°C. Isolates were subcultured in LB broth at 28°C with shaking (250 rpm). Assays were performed using early-exponential-phase cells (A 600 of ϳ0.
2). B. anthracis, E. coli, L. monocytogenes, Y. enterocolitica, Y. pseudotuberculosis, and
Enterococcus and Staphylococcus spp. were cultured using BHI medium at 37°C. Klebsiella, Salmonella, and Shigella spp. were cultured in tryptic soy media, and F. tularensis strains were cultured on BHI or cystine heart agar (CHA) supplemented with 2% hemoglobin. Cultures at an A 600 of 0.2 Ϯ 0.03 were used for experiments. All manipulations were performed within a class II biosafety cabinet.
Bioluminescence assays directly from blood and blood culture bottles. Fresh (Յ1-week-old) whole human blood collected with sodium citrate (Research Blood Components, LLC, Boston, MA) was spiked with Y. pestis A1122 at the indicated concentrations (see Fig. 2 legend) . Spiked blood was diluted 1:20 with LB (50 l into 950 l) in 14-ml culture tubes and incubated at 28°C with shaking (250 rpm). After 4 h of incubation, blood cells were collected by centrifugation (250 ϫ g for 1 to 2 min), and the resulting supernatants were extracted and recentrifuged at 10,000 ϫ g for 4 min. Bacterial cell pellets were resuspended in 225 l of remaining supernatant and mixed with the ⌽A1122::luxAB reporter phage (1.1 ϫ 10 9 PFU/assay). Spiked blood samples were also syringe transferred (5 ml) into blood culture bottles (BacT/Alert Standard Aerobic [bioMérieux, Inc., Durham, NC] or Bactec Plus Aerobic/F culture vials [BD and Co., Sparks, MD]) (final blood dilution factor, 1:9 in BacT/Alert and 1:7 in Bactec bottles). Spiked samples were incubated at 35 to 37°C within BacT/Alert and Bactec blood culture systems. Aliquots from seeded (ϳ10 1 -CFU/ml) culture system-positive Bactec bottles were also assayed without the need for the aforementioned processing and concentration steps. Phage-infected samples were incubated with shaking (250 rpm) for 20 to 45 min. Aliquots (195 l) were added to 96-well microtiter plates and measured for bioluminescence (Glomax 96 Microplate Luminometer 9101-001; Promega Corp., Madison, WI) for 10 s following injection of 2% n-decanal.
Antibiotic resistance/susceptibility profiling from blood. To assess the ability of the reporter phage to detect and simultaneously determine antibiotic susceptibility of Y. pestis in blood, spiked blood samples were mixed with LB containing chloramphenicol, streptomycin, or tetracycline at increasing concentrations throughout known activity ranges and MICs. Samples were treated as described above for bioluminescence assays directly from blood. Antibiotic efficacy was confirmed against the quality control S. aureus strain ATCC 29213 according to the Clinical and Laboratory Standards Institute (CLSI) broth microdilution methods (7, 8) .
Specificity and selectivity assays. Selectivity of the recombinant ⌽A1122::luxAB reporter was assayed for bioluminescence against 59 strains of Y. pestis. Recombinant phage specificity was also determined against 47 strains of closely related genera (i.e., Enterobacteriaceae) and 26 strains of nonrelated but clinically relevant bacterial pathogens through bioluminescence assays. Briefly, log-phase cultures (1 ml) were placed into 14-ml snap-cap tubes (n ϭ 3), infected with ⌽A1122::luxAB, and assayed for bioluminescence over time. Relative bioluminescence (RB) was calculated by dividing the average relative light units (RLU) of Y. pestis A1122 by the average RLU of the test strain. Efficiency of plating (EOP), as defined by the phage titer on a test strain/species compared to the maximum titer, was also analyzed where appropriate using Y. pestis A1122 as the standard (12) . Specific strain data for EOP and relative bioluminescence are provided in Tables S2 and S3 in the supplemental material.
Statistics. Reported as CFU/ml or PFU/ml, all bacterial cell or phage titer concentrations were quantified as the averages of duplicate colony or plaque plate counts, respectively. Bioluminescence values, presented as relative light units (RLU), are the averages of three infections (n ϭ 3) Ϯ standard deviations (SD). All experiments were performed in duplicate. Statistical significance was determined using unpaired Student's t tests. Tukey's adjusted analyses of variance (ANOVAs) were performed for comparisons between multiple data sets, and Pearson's correlation coefficient (r) was used to evaluate dependencies between data sets. Significance was assigned at P Յ 0.05. Statistical analyses were performed using Microsoft Excel 2010 and GraphPad Prism 5.0 on Windows 7.
RESULTS
Selectivity and specificity.
We previously analyzed the ability of ⌽A1122::luxAB to detect Y. pestis A1122, an attenuated exempt select agent strain. However, the functionality of the reporter phage against a range of virulent strains had not been assessed. Therefore, performance was tested against a diverse library of Y. pestis strains (n ϭ 59). In addition, non-Y. pestis Yersinia spp., other Enterobacteriaceae, and distantly related but clinically relevant bacterial pathogens were also analyzed. Of the 59 Y. pestis strains, all (100%) elicited rapid bioluminescence of similar signal intensities and kinetics ( Fig. 1 and data not shown) . For example, after 20 min of ⌽A1122::luxAB infection, Y. pestis CO92 elicited a 100-fold increase in signal compared to controls, with peak light signal manifesting at 40 to 60 min postinfection (Fig. 1) . Doseresponse analysis of 10-fold serially diluted cells indicated that a bioluminescent signal (RLU) was detectable from 2,400, 240, and 24 CFU/ml after 20, 40, and 60 min of infection, respectively ( The reporter phage was used to challenge 70 non-Y. pestis strains for phage-mediated bioluminescence and, in some cases, for phage amplification (EOP assays). These included closely related yersiniae, members of the Enterobacteriaceae, enterococci and staphylococci, and B. anthracis and F. tularensis. Three of 10 Y. enterocolitica strains and 7 of 10 Y. pseudotuberculosis strains elicited phage-mediated bioluminescence (Table 1) . Of these, only one Y. pseudotuberculosis strain expressed a signal as high as 1 log below that of Y. pestis, while the remainder were generally 10 4 -to 10 5 -fold lower. In general, there was a correlation between phagemediated bioluminescence and EOP; strains that elicited low bioluminescence yielded low EOPs.
Due to temperature-dependent differences in lipopolysaccharide (LPS) structure, ⌽A1122 does not form plaques on Y. pseudotuberculosis below 28°C (9, 12). As expected, phage-mediated bioluminescence assays at 20°C revealed an attenuated (10 2 -to 10 4 -fold lower) signal in 5 Y. pseudotuberculosis strains compared to assays performed at 37°C. Unexpectedly, one strain elicited a 10 3 -fold increase at the reduced temperature (data not shown). Among other species, none of the E. coli, Klebsiella, S. boydii, or S. flexneri strains elicited phage-mediated bioluminescence (Table  1) . However, bioluminescence was detected from four S. enterica and two S. sonnei strains, although the signal response was extremely low. As may be expected, none of the phylogenetically distant but clinically relevant strains elicited reporter phage-mediated bioluminescence.
Rapid detection of Y. pestis from blood and blood culture bottles. Because bacteremia is common in bubonic, pneumonic, and septicemic plague, blood is an important matrix for laboratory diagnosis. Blood culture systems can be used to screen for bacteremia. Therefore, the efficacy of reporter phage-mediated detection of Y. pestis A1122 was assessed directly from blood and blood culture bottles. Y. pestis was detected in diluted blood within 5 h, without the need for culture isolation ( Fig. 2A, P Ͻ 0.05) . The signal response exhibited dose-dependent characteristics with a sensitivity limit of detection (LoD) in the 10 2 -CFU/ml range, peaking 45 min after phage infection. Similar results were obtained from BacT/Alert and Bactec culture bottles, indicating a functional compatibility of this detection platform with established clinical procedures for processing blood samples. Although "light" signal measurements were somewhat attenuated in blood, signal production was extremely rapid. Seeded Bactec bottles (n ϭ 6) registered positive for bacterial growth after 24 to 30 h (bloodalone controls did not register positive as expected), and aliquots from these bottles were diagnosed by the reporter phage 20 to 45 min after infection without sample processing or concentration (Fig. 2B and C, P Ͻ 0.05) .
Rapid antibiotic susceptibility profiling from blood. Antimicrobial susceptibility profiling using the reporter phage has been previously demonstrated using pure cultures (14) . To assess the ability of ⌽A1122::luxAB to profile antibiotic susceptibility of Y. pestis without the need for culture isolation, blood samples were spiked with ca. 10 2 CFU/ml Y. pestis and diluted in LB medium containing increasing concentrations of chloramphenicol, streptomycin, or tetracycline along the known MIC ranges (Fig. 3A to C). These antibiotics were selected because they are the standard therapeutics and prophylactics recommended for plague in hu- mans (6) . Samples were incubated for 4 h, infected with ⌽A1122:: luxAB, and then assayed for bioluminescence after 45 min. For each antibiotic, bioluminescence was inversely proportional to antibiotic concentration. High antibiotic concentrations completely nullified signal production, whereas low antibiotic concentrations resulted in strong signals. Thus, rapid detection and simultaneous antibiotic susceptibility profiling of low levels of Y. pestis are achieved through use of the reporter phage detection platform.
DISCUSSION
Plague is definitively diagnosed by the isolation and identification of the organism from clinical specimens or by demonstrating a 4-fold or greater change in antibody titer against the F1 antigen in paired serum specimens. As phage A1122 can be used to identify Y. pestis using classical lysis assays, ⌽A1122::luxAB has the potential to expedite this process. Data obtained using strain A1122 indicated that detection was achieved with blood spiked with 100 CFU/ml within 5 h, with similar results from blood culture. Of note, samples from culture-positive blood bottles were "diagnosed" by the reporter with no preparation, processing, or concentration steps, within 20 to 45 min. Because massive plague bacteremia generally foreshadows a fatal prognosis, and bacteremic concentrations of Ն100 CFU/ml are significantly correlated with mortality, detection of plague bacilli below this level is crucial for a clinically actionable plague diagnostic (6, 15, 16) . ⌽A1122::luxAB efficiently detected all Y. pestis strains tested and likely possesses the same specificity as its parent phage, which infects all but two of thousands of isolates. However, the broad intraspecific host range is counterbalanced by suboptimal crossreactivity, as the reporter transduced bioluminescence to 16 of 47 strains of phylogenetically related species (i.e., Enterobacteriaceae). In cross-reactive strains, amplitude of transduced light was 10 1 -to 10 6 -fold lower (overall median RB ϭ 1.13 ϫ 10 Ϫ5 RLU/ assay) and time to peak signal was generally longer than those for Y. pestis. In receptive Y. pseudotuberculosis strains, assays at subdiagnostic temperature (20°C) revealed signal attenuation by up to 10 4 -fold in most, but not all, strains evaluated. Therefore, the reporter phage may require complementary diagnostic testing to reduce the likelihood of false positives, and particularly to discriminate between Y. pestis and Y. pseudotuberculosis. Importantly, none of the assayed pathogens integral in the differential diagnosis for plague (i.e., B. anthracis, F. tularensis, and Klebsiella pneumoniae) or those most frequently associated with bacteremia (i.e., Enterococcus spp., E. coli, coagulase-negative Staphylococcus spp., and Streptococcus spp.) (17) (18) (19) were positive for bioluminescence. However, as the reporter phage diagnostic requires laboratory equipment and up to 5 h to elicit a response from clinical specimens, it is not usable in its current form as a point-of-care test. In contrast, the plague dipstick tests which target the F1 antigen are specific (no other yersiniae are detected) and sensitive and are particularly useful for field applications as they are rapid (less than 15 min) and do not require equipment (20, 21) . Therefore, dipstick tests have many advantages over the reporter phage technology. However, as F1-negative isolates can occur, albeit rarely (22) , the reporter phage may be a useful alternative to tests that rely on the F1 antigen.
Appropriate antibiotic therapy within 18 to 24 h of symptom onset is essential for a positive prognosis in plague patients (23, 24) . Chloramphenicol, streptomycin, and tetracycline are the recommended primary-level treatments (1, 6) . In addition to the potential for engineered resistance in bioweapons, naturally occurring antibiotic-resistant strains of Y. pestis, although extremely rare, have been isolated (2, 3, 25) . Thus, the ability to rapidly generate an antibiotic susceptibility profile is of value. Immunoassays and most PCR-based methods are unable to distinguish viable from dead cells and are therefore of limited use in determining antibiotic susceptibility. A method employing flow cytometry to determine antibiotic susceptibility following the separation of plague bacilli from spiked blood cultures has been described, although the need for preenrichment extends the assay time to ca. 39 h. The reporter phage diagnostic described here has the ability to detect Y. pestis and to simultaneously determine its susceptibility to antibiotics directly from blood within 5 h. This diagnostic therefore has the potential to provide critical information, timely enough to augment treatment and improve patient outcomes in both bioterrorism and naturally acquired cases of plague.
